Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3422]
News [7838]
Articles [63]
Editorials [9]
Conferences [211]
elearning [49]
Novel multi-antigen targeted CAR-NK cell for the treatment of B cell...
Dr Bahram Valamehr - Fate Therapeutics Inc., San Diego, USA
Novel multi-antigen targeted CAR-NK cell for the treatment of B cell malignancies ( Dr Bahram Valamehr - Fate Therapeutics Inc., San Diego, USA )
9 Dec 2019
JCOG: The Japan Clinical Oncology Group
Dr Tomonori Mizutani - Kyorin University, Mitaka, Tokyo
JCOG: The Japan Clinical Oncology Group ( Dr Tomonori Mizutani - Kyorin University, Mitaka, Tokyo )
4 Dec 2019
Exploring TKIs in metastatic sarcomas: Results of REGOBONE osteosarcoma cohort
Professor Jean-Yves Blay and Professor Florence Duffaud
Exploring TKIs in metastatic sarcomas: Results of REGOBONE osteosarcoma cohort ( Professor Jean-Yves Blay and Professor Florence Duffaud )
14 Nov 2019
REGOSARC – activity of regorafenib in advanced non-adipocytic STS
Professor Jean-Yves Blay and Professor Florence Duffaud
REGOSARC – activity of regorafenib in advanced non-adipocytic STS ( Professor Jean-Yves Blay and Professor Florence Duffaud )
14 Nov 2019
PROfound: PARP inhibitor olaparib compared with new hormonal agents in advanced...
Prof Maha Hussain - Northwestern University Feinberg School of Medicine...
PROfound: PARP inhibitor olaparib compared with new hormonal agents in advanced castration resistant prostate cancer ( Prof Maha Hussain - Northwestern University Feinberg School of Medicine, Chicago, USA )
7 Nov 2019
Analysis of assay used in IMpassion130 to guide treatment of metastatic and...
Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
Analysis of assay used in IMpassion130 to guide treatment of metastatic and advanced breast cancers ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
31 Oct 2019
Treatment pathways for patients with triple-negative breast cancer
Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA
Treatment pathways for patients with triple-negative breast cancer ( Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA )
23 Oct 2019
PARP inhibitors in metastatic breast cancer: The present and the future
Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA
PARP inhibitors in metastatic breast cancer: The present and the future ( Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA )
23 Oct 2019
The treatment landscape of occular melanoma
Maitry Patel CCPA - Princess Margaret Cancer Centre, Toronto, Canada
The treatment landscape of occular melanoma ( Maitry Patel CCPA - Princess Margaret Cancer Centre, Toronto, Canada )
21 Oct 2019
Immunotherapy in gastric cancers
Dr. Manish A. Shah - Mayo Clinic, Rochester, USA
Immunotherapy in gastric cancers ( Dr. Manish A. Shah - Mayo Clinic, Rochester, USA )
21 Oct 2019
The challenge of detecting NTRK fusions across tumour types
Professor Dr Marc Peeters, Professor Caterina Marchio
The challenge of detecting NTRK fusions across tumour types ( Professor Dr Marc Peeters, Professor Caterina Marchio )
21 Oct 2019
Shaping the future of metastasis - ecancer investigates
Monique Biryiana - ecancer Medical Reporter, Dr Chris Bakal - Dynamical Cell...
Shaping the future of metastasis - ecancer investigates ( Monique Biryiana - ecancer Medical Reporter, Dr Chris Bakal - Dynamical Cell Systems Team Leader, Patricia Pascual Vargas - PhD Student )
14 Oct 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation